Founded in Houston, Texas, a pioneering synthetic biology company is on a mission to decarbonize heavy industry by engineering microorganisms inspired by extremophiles that thrive in harsh environments to use carbon dioxide and methane as feedstocks for producing industrial chemicals, sustainable aviation fuel, and other high-value products. The company works at the intersection of biotechnology, chemical manufacturing, and clean energy, partnering with major energy and mining corporations to develop scalable biomanufacturing solutions that reduce carbon emissions while creating new revenue streams. With R&D teams conducting cutting-edge genetic engineering, pilot plant development, and bioprocess optimization work across multiple verticals, TaxTaker was engaged to evaluate the company's eligibility for the R&D Tax Credit.

TaxTaker's team worked closely with the company's scientists and engineers to document qualifying research activities spanning genetic engineering and metabolic pathway design, development of CO2-to-chemical conversion processes, microbial strain optimization, bench-to-pilot scale-up experiments, and proprietary bioprocess engineering for applications in sustainable aviation fuel and bio-based chemical production. Each activity underwent a detailed four-part qualification analysis, with TaxTaker ensuring the company's extensive lab documentation, experimental records, and engineering notebooks were properly organized to support a defensible credit claim.

The engagement identified approximately $491,400 in qualifying federal R&D wages and related expenses, along with $87,600 in eligible state-level qualifying costs, yielding a total combined R&D Tax Credit of roughly $579,000. These non-dilutive funds were deployed to accelerate the company's pre-commercial demonstration plant development and support its expanding portfolio of biomanufacturing client projects. The result demonstrates that synthetic biology companies whose entire business model is built on experimental biological systems represent one of the strongest R&D credit opportunities in the cleantech sector.